• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CT 的影像组学模型预测口腔鳞状细胞癌对免疫治疗的反应。

Predicting response to immunotherapy in oral squamous cell carcinoma via a CT-based radiomics model.

机构信息

Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No.639 Zhizaoju Road, Shanghai, 200010, China.

出版信息

BMC Med Imaging. 2024 Oct 7;24(1):266. doi: 10.1186/s12880-024-01444-9.

DOI:10.1186/s12880-024-01444-9
PMID:39375583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11460018/
Abstract

BACKGROUND

To investigate whether radiomics models derived from pretreatment CT could help to predict response to immunotherapy in oral squamous cell carcinoma (OSCC).

METHODS

Retrospectively, a total of 40 patients with measurable OSCC were included. The patients were divided into responder group and non-responder group according to the comparison of pre-treatment and post-treatment CT findings. Radiomics features were extracted from pre-treatment CT images, and optimal features were selected by univariate analysis and the least absolute shrinkage and selection operator (LASSO) regression analysis. Neural network, support vector machine, random forest and logistic regression models were used to predict response to immunotherapy in OSCC, and leave-one-out cross validation was employed to assess the performance of the classifiers. The area under the curve (AUC), accuracy, sensitivity and specificity were calculated to quantify the predictive efficacy.

RESULTS

A total of 7 features were selected to build models upon machine learning methods. By comparing different machine learning based models, the neural network model achieved the best predictive ability, with an AUC of 0.864, an accuracy of 82.5%, a sensitivity of 82.5%, and a specificity of 82.5%.

CONCLUSIONS

The pretreatment CT-based radiomics model showed good performance in predicting response to immunotherapy in OSCC. Pretreatment CT-based radiomics model might provide an alternative approach for the selection of patients who benefit from immunotherapy.

摘要

背景

为了探究基于治疗前 CT 的影像组学模型是否有助于预测口腔鳞状细胞癌(OSCC)对免疫治疗的反应。

方法

回顾性纳入 40 例可测量的 OSCC 患者。根据治疗前和治疗后 CT 检查结果的比较,将患者分为应答组和无应答组。从治疗前 CT 图像中提取影像组学特征,通过单因素分析和最小绝对值收缩和选择算子(LASSO)回归分析选择最优特征。采用神经网络、支持向量机、随机森林和逻辑回归模型预测 OSCC 对免疫治疗的反应,采用留一法交叉验证评估分类器的性能。计算曲线下面积(AUC)、准确性、敏感度和特异度来量化预测效果。

结果

通过机器学习方法共选择了 7 个特征来构建模型。通过比较不同的基于机器学习的模型,神经网络模型具有最佳的预测能力,AUC 为 0.864,准确性为 82.5%,敏感度为 82.5%,特异度为 82.5%。

结论

基于治疗前 CT 的影像组学模型在预测 OSCC 对免疫治疗的反应方面表现出良好的性能。基于治疗前 CT 的影像组学模型可能为选择受益于免疫治疗的患者提供一种替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/a88538189fd3/12880_2024_1444_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/4d2740cba190/12880_2024_1444_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/2c20a7f5555a/12880_2024_1444_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/d1c033eea963/12880_2024_1444_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/0436abd817b6/12880_2024_1444_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/a88538189fd3/12880_2024_1444_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/4d2740cba190/12880_2024_1444_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/2c20a7f5555a/12880_2024_1444_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/d1c033eea963/12880_2024_1444_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/0436abd817b6/12880_2024_1444_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ba/11460018/a88538189fd3/12880_2024_1444_Fig5_HTML.jpg

相似文献

1
Predicting response to immunotherapy in oral squamous cell carcinoma via a CT-based radiomics model.基于 CT 的影像组学模型预测口腔鳞状细胞癌对免疫治疗的反应。
BMC Med Imaging. 2024 Oct 7;24(1):266. doi: 10.1186/s12880-024-01444-9.
2
A prediction model for degree of differentiation for resectable locally advanced esophageal squamous cell carcinoma based on CT images using radiomics and machine-learning.基于 CT 图像的放射组学和机器学习建立可切除局部晚期食管鳞癌分化程度预测模型。
Br J Radiol. 2021 Aug 1;94(1124):20210525. doi: 10.1259/bjr.20210525. Epub 2021 Jul 8.
3
A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma.基于增强 CT 的机器学习放射组学预测可切除食管鳞癌新辅助免疫治疗。
Front Immunol. 2024 Jun 14;15:1405146. doi: 10.3389/fimmu.2024.1405146. eCollection 2024.
4
Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.基于机器学习的放射组学策略预测非小细胞肺癌细胞增殖。
Eur J Radiol. 2019 Sep;118:32-37. doi: 10.1016/j.ejrad.2019.06.025. Epub 2019 Jun 28.
5
Prognostic value of F-FDG PET radiomics and sarcopenia in patients with oral squamous cell carcinoma.18F-FDG PET 影像组学与骨骼肌减少症对口腔鳞状细胞癌患者预后的预测价值。
Med Phys. 2024 Jul;51(7):4907-4921. doi: 10.1002/mp.16949. Epub 2024 Jan 22.
6
Clear cell renal cell carcinoma: Machine learning-based computed tomography radiomics analysis for the prediction of WHO/ISUP grade.透明细胞肾细胞癌:基于机器学习的 CT 影像组学分析预测 WHO/ISUP 分级。
Eur J Radiol. 2019 Dec;121:108738. doi: 10.1016/j.ejrad.2019.108738. Epub 2019 Nov 6.
7
Machine learning model based on enhanced CT radiomics for the preoperative prediction of lymphovascular invasion in esophageal squamous cell carcinoma.基于增强CT影像组学的机器学习模型用于术前预测食管鳞状细胞癌的淋巴管侵犯
Front Oncol. 2024 Feb 23;14:1308317. doi: 10.3389/fonc.2024.1308317. eCollection 2024.
8
Multimodality radiomics prediction of radiotherapy-induced the early proctitis and cystitis in rectal cancer patients: a machine learning study.多模态放射组学预测直肠癌患者放疗诱导的早期直肠炎和膀胱炎:一项机器学习研究。
Biomed Phys Eng Express. 2023 Dec 20;10(1). doi: 10.1088/2057-1976/ad0f3e.
9
Prediction of squamous cell carcinoma cases from squamous cell hyperplasia in throat lesions using CT radiomics model.基于 CT 影像组学模型预测咽喉病变中鳞状细胞增生向鳞状细胞癌的转化。
Saudi Med J. 2021 Mar;42(3):284-292. doi: 10.15537/smj.2021.42.3.20200617.
10
[Value of the application of enhanced CT radiomics and machine learning in preoperative prediction of microvascular invasion in hepatocellular carcinoma].[增强CT影像组学与机器学习在肝细胞癌微血管侵犯术前预测中的应用价值]
Zhonghua Yi Xue Za Zhi. 2021 May 11;101(17):1239-1245. doi: 10.3760/cma.j.cn112137-20200820-02425.

本文引用的文献

1
Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer.基于人工智能的肺癌免疫治疗和靶向治疗临床结局预测。
Semin Cancer Biol. 2022 Nov;86(Pt 2):146-159. doi: 10.1016/j.semcancer.2022.08.002. Epub 2022 Aug 11.
2
Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.新辅助化疗免疫治疗局部晚期头颈部鳞状细胞癌:单臂 2 期临床试验。
Clin Cancer Res. 2022 Aug 2;28(15):3268-3276. doi: 10.1158/1078-0432.CCR-22-0666.
3
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
帕博利珠单抗单药或联合化疗治疗复发/转移性头颈部鳞状细胞癌的 KEYNOTE-048 研究:程序性死亡配体-1 联合阳性评分的亚组分析。
J Clin Oncol. 2022 Jul 20;40(21):2321-2332. doi: 10.1200/JCO.21.02198. Epub 2022 Mar 25.
4
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.放射组学分析预测晚期罕见癌症患者对 pembrolizumab 的反应。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-001752.
5
Nodal-based radiomics analysis for identifying cervical lymph node metastasis at levels I and II in patients with oral squamous cell carcinoma using contrast-enhanced computed tomography.基于淋巴结的放射组学分析在使用对比增强 CT 对口腔鳞状细胞癌患者Ⅰ、Ⅱ水平的颈淋巴结转移的识别。
Eur Radiol. 2021 Oct;31(10):7440-7449. doi: 10.1007/s00330-021-07758-4. Epub 2021 Mar 31.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.基于 CT 的放射组学特征与晚期实体瘤免疫检查点抑制剂治疗反应相关。
Radiology. 2021 Apr;299(1):109-119. doi: 10.1148/radiol.2021200928. Epub 2021 Jan 26.
8
Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC.基于治疗前CT的影像组学特征作为预测食管鳞癌中PD-L1表达和CD8+肿瘤浸润淋巴细胞的潜在影像生物标志物
Onco Targets Ther. 2020 Nov 20;13:12003-12013. doi: 10.2147/OTT.S261068. eCollection 2020.
9
[Clinical comment of programmed cell death protein 1 immunotherapy for advanced head and neck cancer].程序性细胞死亡蛋白1免疫疗法治疗晚期头颈癌的临床评论
Hua Xi Kou Qiang Yi Xue Za Zhi. 2020 Oct 1;38(5):489-494. doi: 10.7518/hxkq.2020.05.003.
10
Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.基于放射组学的 PD-1/PD-L1 免疫治疗转移性尿路上皮癌结局预测模型。
Eur Radiol. 2020 Oct;30(10):5392-5403. doi: 10.1007/s00330-020-06847-0. Epub 2020 May 12.